Bortolato M, Frau R, Orr M, Bourov Y, Marrosu F, Mereu G, et al
The ruling offers a potential conclusion to a lawsuit which was filed in 2016 and went to trial in November, however Coke and Monster could still appeal the decision
menciona que casi no hay reportes de reacciones adversas y sugiere que podra ser una herramienta prometedora para lesiones hipovasculares)pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov
Department of Oral Biology, Goldschleger School of Dental Medicine, Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel * Correspondence: Rachel Amir ([email protected]) Received date: 2024-03-26 Accepted date: 2024-10-08 Online published: 2024-10-24 Supported by This work was supported by the Israel Science Foundation (ISF Grant no